Publikationen

Affengruber, L.; Grillich, L.; Schultes, M.T.; Sommer, I. (2026). Evaluation of “Sport for the Strong” – A project for the integration of children and adolescents with special educational needs into club sports. Evaluating and Program Planning, 114: 102700

Gray, A.P.; et. al.; Sharifan, A. (2025). Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis. The Lancet Global Health, 13, 12: E2013-2026

Flemyng, E.; Noel-Storr, A.; Macura, B.; Gartlehner, G.; Thomas, J.; Meerpohl, J.J.; Jordan, Z.; Minx, J.; Eisele-Metzger, A.; Hamel, C.; Jemiolo, P.; Porritt, K.; Grainger, M. (2025). Position statement on artificial intelligence (AI) use in evidence synthesis across Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence 2025. Cochrane Database of Systematic Reviews, 11: https://doi.org/10.1002/14651858.ED000178

Nussbaumer-Streit, B.; Booth, A.; Garritty, C.; Hamel, C.; Munn, Z.; Tricco, A.C.; Pollock, D. (2025). Overview of evidence synthesis types and modes. Journal of Clinical Epidemiology, 187: 111970

Gartlehner, G.; Nussbaumer-Streit, B.; Hamel, C.; Garritty, C.; Griebler, U.; King, V.J.; Devane, D.; Kamel, C. (2025). Responsible Integration of Artificial Intelligence in Rapid Reviews: A Position Statement From the Cochrane Rapid Reviews Methods Group. Cochrane Evidence Synthesis and Methods, 4:e70063: https://doi.org/10.1002/cesm.70063

Dobrescu, A.I.; Sharifan, A.; Sommer, I.; Neubauer-Bruckner, C.I.A.; Gadinger, A.; Klerings, I.; Nowak, C.; Gartlehner, G. (2025). Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of prin: 10.7326/ANNALS-25-04028

Gartlehner, G.; Kugley, S.; Crotty, K.; Viswanathan, M.; Dobrescu, A.; Nussbaumer-Streit, B.; Booth, G.; Treadwell, J.R.; Min Han, J.; Wagner, J.; Apaydin, E.A.; Coppola, E.L.; Maglione, M.; Hilscher, R.; Chew, R.; Pilar, M.; Swanton, B.; Kahwati, L. (2025). Artificial Intelligence–Assisted Data Extraction With a Large Language Model: A Study Within Reviews. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-00739

Sharifan, A.; Dobrescu, A.; Harrod, C.; Klerings, I.; Yuhan Ong, A.; Ngeh, E.; Xiao, Y.-T.; Gartlehner, G. (2025). Approaches for reporting and interpreting statistically nonsignificant findings in evidence syntheses: A systematic review. Journal of Clinical Epidemiology, in press: https://doi.org/10.1016/j.jclinepi.2025.112083

Mestrovic, T.; et. al.; Sharifan, A. (2025). The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050. The Lancet Public Health, 10, 11: E955-970

Movsisyan, A.; Asres Ioab, K.; Himmels, J.W.; Bantle, G.L.; Dobrescu, A.; Flottorp, S.; Forland, F.; Gadinger, A.; Koscher-Kien, C.; Klerings, I.; Meerpohl, J.J.; Nussbaumer-Streit, B.; Strahwald, B.; Rehfuess, E.A. (2025). Conducting evidence synthesis and developing evidence-based advice in public health and beyond: A scoping review and map of methods guidance. Research Synthesis Methods, 00: 1-25

Sharifan, A. (2025). Navigating the grey area: “Trend” statements to report statistical findings in the critical care literature. Journal of Critical Care, 89: 155162

Dobrescu, A.; Nussbaumer-Streit, B.; Wagner, G.; Sharifan, A.; Gadinger, A.; Klerings, I.; Nowak, C.; Gartlehner, G. (2025). Assessing the Impact of Unpublished Data on Network Meta-Analysis Outcomes in Outpatient Adults with Acute Migraine: A Study within a Review. Journal of Clinical Epidemiology, 112014: https://doi.org/10.1016/j.jclinepi.2025.112014

Braun, A.; Hyll, W.; Krczal, E. (2025). Breaking the habit: a systematic review of the cost-effectiveness of non-pharmacological and combined interventions for smoking cessation in Europe. The European Journal of Health Economics, epub: 1-25

GBD 2023 Cancer Collaborators; Sharifan, A. (2025). The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406, 10512: P1565-1586

Flemyng, E.; Noel-Storr, A.; Macura, B.; Gartlehner, G.; Thomas, J.; Meerpohl J.J.; Jordan, Z.; Minx, J.; Eisele-Metzger, A.; Hamel, C.; Jemiolo, P.; Porritt, K., Grainger, M. (2025). Position Statement on Artificial Intelligence (AI) Use in Evidence Synthesis Across Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence 2025. Campbell Systematic Reviews, 21: https://doi.org/10.1002/cl2.70074

GBD 2021 Headache Collaborators; Sharifan, A. (2025). Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Reports Medicine, 6, 10: 102348

Flemyng, E.; Noel-Storr, A.; Macura, B.; Gartlehner, G.; Thomas, J.; Meerpohl, J.J.; Jordan, Z.; Minx, J.; Eisele-Metzger, A.; Hamel, C.; Jemiolo, P.; Porritt, K.; Grainger, M. (2025). Position statement on artificial intelligence (AI) use in evidence synthesis across Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence 2025. Environmental Evidence, 14:20: 10.1186/s13750-025-00374-5.

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Hay, S.I.; et. al.; Sharifan, A. (2025). Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 20. The Lancet, 406, 10513: P1873-1922

Schumacher, A.E.; et. al.; Sharifan, A. (2025). Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023. The Lancet, 406, 10513: P1731-1810